STEVEN GILLIS
Listed on 6 Form D filings across 5+ issuers
· Director, Executive Officer
Associated issuers
- ARCH Venture Fund XIV, L.P. CIK 2138046 · Illinois
- SonoThera, Inc. CIK 1945154 · California
- Pheast Therapeutics, Inc. CIK 1943737 · California
- OncoResponse, Inc CIK 1655774 · Texas
- Proniras Corp CIK 1715327 · Washington
Filings (6)
-
ARCH Venture Fund XIV, L.P.D · Aug 31, 2026 · Illinois · Pooled Investment Fund$3BView filing →
-
SonoThera, Inc.D · Jun 30, 2026 · California · Biotechnology$125.5MView filing →
-
Pheast Therapeutics, Inc.D · Oct 16, 2025 · California · Other Technology$40MView filing →
-
OncoResponse, IncD · May 6, 2025 · Texas · Biotechnology
-
Pheast Therapeutics, Inc.D/A · Apr 10, 2025 · California · Other Technology$75.2MView filing →
-
Proniras CorpD/A · Jan 29, 2025 · Washington · Other$12.2MView filing →